Company intelligence / Profile preview

Oculus Technologies of Mexico

Ownership: Private
Development stage: Other

Overview

Oculus Technologies of Mexico, a subsidiary of Sonoma Pharmaceuticals (formerly Oculus Innovative Sciences), manufactures and exports Microcyn-based healthcare products targeting wound healing, oral care, dermatology, animal health and surgical infections. Products are commercially available in multiple international markets and have received regulatory approvals for both prescription and OTC uses in Mexico and other countries[1][5][7][8][12].

Therapeutic areas: OtherWomen's HealthDermatologyInfectious Diseases
Modalities: DeviceBiologic
Industry: Therapeutic Medical Devices

Partnerships

More Pharma

Beyond the preview

Go deeper on Oculus Technologies of Mexico.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oculus Technologies of Mexico.